Synopsis
Synopsis
0
VMF
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Molecular Weight | 326.8 g/mol |
---|---|
Molecular Formula | C18H19ClN4 |
XLogP3 | 3.2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 1 |
Exact Mass | 326.1298243 g/mol |
Monoisotopic Mass | 326.1298243 g/mol |
Topological Polar Surface Area | 30.9 A^2 |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 584 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 6 | |
---|---|
Drug Name | Clozapine |
PubMed Health | Clozapine (By mouth) |
Drug Classes | Antipsychotic |
Drug Label | VERSACLOZ, an atypical antipsychotic drug, is a tricyclic dibenzodiazepine derivative, 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine.The structural formula is: VERSACLOZ is available as a free-flowing yellow suspension. Each mL c... |
Active Ingredient | Clozapine |
Dosage Form | Tablet |
Route | Oral |
Strength | 200mg; 100mg; 25mg; 50mg; 12.5mg |
Market Status | Prescription |
Company | Ivax Sub Teva Pharms; Sun Pharm Inds; Mylan |
2 of 6 | |
---|---|
Drug Name | Clozaril |
PubMed Health | Clozapine (By mouth) |
Drug Classes | Antipsychotic |
Drug Label | CLOZARIL (clozapine), an atypical antipsychotic drug, is a tricyclic dibenzodiazepine derivative, 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo [b,e] [1,4] diazepine.The structural formula isCLOZARIL is available in pale yellow tablets of 25mg... |
Active Ingredient | Clozapine |
Dosage Form | Tablet |
Route | Oral |
Strength | 100mg; 25mg |
Market Status | Prescription |
Company | Novartis |
3 of 6 | |
---|---|
Drug Name | Fazaclo odt |
Active Ingredient | Clozapine |
Dosage Form | Tablet, orally disintegrating |
Route | Oral |
Strength | 200mg; 100mg; 25mg; 150mg; 12.5mg |
Market Status | Prescription |
Company | Jazz Pharms Iii |
4 of 6 | |
---|---|
Drug Name | Clozapine |
PubMed Health | Clozapine (By mouth) |
Drug Classes | Antipsychotic |
Drug Label | VERSACLOZ, an atypical antipsychotic drug, is a tricyclic dibenzodiazepine derivative, 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine.The structural formula is: VERSACLOZ is available as a free-flowing yellow suspension. Each mL c... |
Active Ingredient | Clozapine |
Dosage Form | Tablet |
Route | Oral |
Strength | 200mg; 100mg; 25mg; 50mg; 12.5mg |
Market Status | Prescription |
Company | Ivax Sub Teva Pharms; Sun Pharm Inds; Mylan |
5 of 6 | |
---|---|
Drug Name | Clozaril |
PubMed Health | Clozapine (By mouth) |
Drug Classes | Antipsychotic |
Drug Label | CLOZARIL (clozapine), an atypical antipsychotic drug, is a tricyclic dibenzodiazepine derivative, 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo [b,e] [1,4] diazepine.The structural formula isCLOZARIL is available in pale yellow tablets of 25mg... |
Active Ingredient | Clozapine |
Dosage Form | Tablet |
Route | Oral |
Strength | 100mg; 25mg |
Market Status | Prescription |
Company | Novartis |
6 of 6 | |
---|---|
Drug Name | Fazaclo odt |
Active Ingredient | Clozapine |
Dosage Form | Tablet, orally disintegrating |
Route | Oral |
Strength | 200mg; 100mg; 25mg; 150mg; 12.5mg |
Market Status | Prescription |
Company | Jazz Pharms Iii |
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code :
Brand Name : CLOZAPINE
Dosage Form : TABLET;ORAL
Dosage Strength : 25MG
Approval Date : 2015-09-17
Application Number : 203807
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code :
Brand Name : CLOZAPINE
Dosage Form : TABLET;ORAL
Dosage Strength : 100MG
Approval Date : 2015-09-17
Application Number : 203807
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code :
Brand Name : CLOZAPINE
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Approval Date : 2017-08-22
Application Number : 203807
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code :
Brand Name : CLOZAPINE
Dosage Form : TABLET;ORAL
Dosage Strength : 200MG
Approval Date : 2017-08-22
Application Number : 203807
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.
RLD : Yes
TE Code :
Brand Name : VERSACLOZ
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 50MG/ML
Approval Date : 2013-02-06
Application Number : 203479
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : No
TE Code : AB
Brand Name : CLOZAPINE
Dosage Form : TABLET;ORAL
Dosage Strength : 100MG
Approval Date : 2015-11-25
Application Number : 202873
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Brand Name : CLOZAPINE
Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL
Dosage Strength : 100MG
Approval Date : 2015-11-25
Application Number : 90308
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code :
Brand Name : CLOZAPINE
Dosage Form : TABLET;ORAL
Dosage Strength : 12.5MG
Approval Date : 2003-07-31
Application Number : 74949
RX/OTC/DISCN : RX
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : FAZACLO ODT
Dosage Form : TABLET, ORALLY DISINTEGRATING;ORAL
Dosage Strength : 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date : 2005-06-03
Application Number : 21590
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : CLOZAPINE
Dosage Form : TABLET;ORAL
Dosage Strength : 25MG
Approval Date : 2002-11-15
Application Number : 75713
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
51
PharmaCompass offers a list of Clozapine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Clozapine manufacturer or Clozapine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Clozapine manufacturer or Clozapine supplier.
PharmaCompass also assists you with knowing the Clozapine API Price utilized in the formulation of products. Clozapine API Price is not always fixed or binding as the Clozapine Price is obtained through a variety of data sources. The Clozapine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Lodux manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lodux, including repackagers and relabelers. The FDA regulates Lodux manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lodux API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lodux manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Lodux supplier is an individual or a company that provides Lodux active pharmaceutical ingredient (API) or Lodux finished formulations upon request. The Lodux suppliers may include Lodux API manufacturers, exporters, distributors and traders.
click here to find a list of Lodux suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Lodux DMF (Drug Master File) is a document detailing the whole manufacturing process of Lodux active pharmaceutical ingredient (API) in detail. Different forms of Lodux DMFs exist exist since differing nations have different regulations, such as Lodux USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Lodux DMF submitted to regulatory agencies in the US is known as a USDMF. Lodux USDMF includes data on Lodux's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Lodux USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Lodux suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Lodux Drug Master File in Japan (Lodux JDMF) empowers Lodux API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Lodux JDMF during the approval evaluation for pharmaceutical products. At the time of Lodux JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Lodux suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Lodux Drug Master File in Korea (Lodux KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Lodux. The MFDS reviews the Lodux KDMF as part of the drug registration process and uses the information provided in the Lodux KDMF to evaluate the safety and efficacy of the drug.
After submitting a Lodux KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Lodux API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Lodux suppliers with KDMF on PharmaCompass.
A Lodux CEP of the European Pharmacopoeia monograph is often referred to as a Lodux Certificate of Suitability (COS). The purpose of a Lodux CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Lodux EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Lodux to their clients by showing that a Lodux CEP has been issued for it. The manufacturer submits a Lodux CEP (COS) as part of the market authorization procedure, and it takes on the role of a Lodux CEP holder for the record. Additionally, the data presented in the Lodux CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Lodux DMF.
A Lodux CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Lodux CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Lodux suppliers with CEP (COS) on PharmaCompass.
A Lodux written confirmation (Lodux WC) is an official document issued by a regulatory agency to a Lodux manufacturer, verifying that the manufacturing facility of a Lodux active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Lodux APIs or Lodux finished pharmaceutical products to another nation, regulatory agencies frequently require a Lodux WC (written confirmation) as part of the regulatory process.
click here to find a list of Lodux suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Lodux as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Lodux API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Lodux as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Lodux and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Lodux NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Lodux suppliers with NDC on PharmaCompass.
Lodux Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lodux GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lodux GMP manufacturer or Lodux GMP API supplier for your needs.
A Lodux CoA (Certificate of Analysis) is a formal document that attests to Lodux's compliance with Lodux specifications and serves as a tool for batch-level quality control.
Lodux CoA mostly includes findings from lab analyses of a specific batch. For each Lodux CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lodux may be tested according to a variety of international standards, such as European Pharmacopoeia (Lodux EP), Lodux JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lodux USP).